SeaStar Medical Holding Corporation - Common Stock ICU 深 滬
已收盤 10-03 16:00:00 美东时间
0.6486
-0.036
-5.31%
華盛通- 最 高0.71
- 今 開0.6899
- 成交量 252.78万股
- 最 低 0.6147
- 昨 收 0.685
- 總市值 1786.65万
- 52周最高 4.28
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 0.3054
- 委 比 14.44%
- 總股本 2754.63万
- 歷史最高 305.00
- 量 比 0.56
- 振 幅 13.91%
- 歷史最低 0.3054
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多波动到底是风险还是收益？一文说清各种应对波动的策略
不是风动是心动 A基金的长期年化收益率为15%，但在大盘调整时，经常出现超过20%的回撤；B基金的长期年化收益率为10%，但每次大盘调整，回撤不会超过5%，你...
09-28 19:26
迈瑞、美敦力强势押注这一新赛道！
（来源：医疗器械创新网） 商业决策上，企业对业务的重视度，都藏在真金白银的投入里。 美敦力以“五年内向英国投入数千万美元投资”锚定 AI 与机器人...
09-28 17:45
国金医药甘坛焕丨恩华药业深度：自研新药报产迎破局，创新步入收获期
（来源：国金证券研究所） 作者：甘坛焕 摘要 麻龙头再起航，高壁垒产品助增长。(1)历久弥新，公司历年总营收及归母净利润均保持稳健增长，过去十年（2...
09-26 16:33
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
SeaStar Medical announced that an independent DSMB has recommended continuation of its NEUTRALIZE-AKI pivotal trial of the Selective Cytopheretic Device (SCD) therapy for adult patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). The interim analysis of the first 100 patients found no device-related safety concerns and a potential clinical benefit signal across key outcomes. The DSMB recommended increasin...
09-24 20:22
《Critical Care》重磅发表！迈瑞&华西破解Pmus无创实时监测难题
迈瑞&华西创新研究成果——呼吸努力Pmus(respiratory muscle pressure)无创实时监测技术，近日发表于影响因子9.3的重症医学...
09-24 15:25
SeaStar Medical To Present Preliminary SAVE Surveillance Registry Data On QUELIMMUNE Therapy For Pediatric AKI And Sepsis At The 5th International Symposium On Acute Kidney Injury In Children
SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be presented by SeaStar Medical and its research
09-23 20:26
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
SeaStar Medical will present preliminary results from the SAVE Surveillance Registry at the 5th International Symposium on Acute Kidney Injury in Children, highlighting QUELIMMUNE therapy's role in treating critically ill pediatric patients with life-threatening AKI and sepsis requiring RRT. The registry aims to confirm the therapy's safety and efficacy in real-world settings, with data including 90-day survival rates and dialysis dependency. The...
09-23 12:23
安井食品“盯上”冷冻烘焙赛道
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：北京商报 近日，安井食品召开了2025年半年度业绩说明会，针对海外...
09-18 21:53
汽车行业如此卷，为什么还有新人要进来？
原标题：汽车行业如此卷，为什么还有新人要进来？ 一个汽车行业的共识是：汽车行业正处于残酷的大洗牌时期，未来将只有5家汽车公司。 传统汽车巨头目标是“活下去”...
09-17 18:54
波动到底是风险还是收益？一文说清各种应对波动的策略︱重阳荐文
波动不是风险本身，真正的风险是“永久性损失”，但波动是风险的表现形式：它触发了投资者的恐惧和行为偏差，让风险变为现实，也让交易对手有了赚钱的机会。 由此出现了...
09-16 15:30
